Clifford Swan Investment Counsel LLC Sells 5,063 Shares of Colgate-Palmolive (NYSE:CL)

Clifford Swan Investment Counsel LLC trimmed its stake in Colgate-Palmolive (NYSE:CL) by 2.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 200,290 shares of the company’s stock after selling 5,063 shares during the period. Clifford Swan Investment Counsel LLC’s holdings in Colgate-Palmolive were worth $15,965,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Bailard Inc. grew its position in Colgate-Palmolive by 25.2% during the third quarter. Bailard Inc. now owns 7,875 shares of the company’s stock valued at $560,000 after acquiring an additional 1,584 shares during the last quarter. JB Capital LLC grew its position in Colgate-Palmolive by 7.4% during the third quarter. JB Capital LLC now owns 49,697 shares of the company’s stock valued at $3,534,000 after acquiring an additional 3,436 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its position in Colgate-Palmolive by 2.2% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 253,749 shares of the company’s stock valued at $18,044,000 after acquiring an additional 5,445 shares during the last quarter. Mackenzie Financial Corp grew its position in Colgate-Palmolive by 4.7% during the third quarter. Mackenzie Financial Corp now owns 3,837,192 shares of the company’s stock valued at $270,407,000 after acquiring an additional 171,397 shares during the last quarter. Finally, Deane Retirement Strategies Inc. bought a new position in Colgate-Palmolive during the third quarter valued at approximately $1,776,000. 80.41% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, CEO Noel R. Wallace sold 69,948 shares of Colgate-Palmolive stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $84.22, for a total value of $5,891,020.56. Following the completion of the sale, the chief executive officer now directly owns 286,881 shares in the company, valued at approximately $24,161,117.82. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other Colgate-Palmolive news, CEO Noel R. Wallace sold 50,000 shares of the business’s stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $83.15, for a total transaction of $4,157,500.00. Following the completion of the sale, the chief executive officer now directly owns 274,179 shares in the company, valued at approximately $22,797,983.85. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Noel R. Wallace sold 69,948 shares of the business’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $84.22, for a total value of $5,891,020.56. Following the sale, the chief executive officer now owns 286,881 shares of the company’s stock, valued at $24,161,117.82. The disclosure for this sale can be found here. In the last ninety days, insiders sold 159,048 shares of company stock worth $13,336,846. 0.34% of the stock is owned by corporate insiders.

Colgate-Palmolive Trading Down 0.0 %

CL stock traded down $0.03 on Friday, reaching $92.88. The company’s stock had a trading volume of 5,432,695 shares, compared to its average volume of 4,878,342. The business has a fifty day simple moving average of $88.35 and a two-hundred day simple moving average of $82.35. Colgate-Palmolive has a 12-month low of $67.62 and a 12-month high of $93.25. The firm has a market cap of $76.20 billion, a PE ratio of 29.39, a PEG ratio of 3.43 and a beta of 0.40. The company has a debt-to-equity ratio of 13.21, a quick ratio of 0.28 and a current ratio of 1.06.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, April 26th. The company reported $0.86 EPS for the quarter, beating the consensus estimate of $0.82 by $0.04. The business had revenue of $5.07 billion during the quarter, compared to analyst estimates of $4.96 billion. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. The company’s revenue for the quarter was up 6.2% on a year-over-year basis. During the same quarter last year, the firm posted $0.73 earnings per share. As a group, research analysts forecast that Colgate-Palmolive will post 3.52 EPS for the current year.

Colgate-Palmolive Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Monday, April 22nd will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, April 19th. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. This represents a $2.00 annualized dividend and a dividend yield of 2.15%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 63.29%.

Wall Street Analysts Forecast Growth

CL has been the topic of a number of recent research reports. Stifel Nicolaus increased their price target on shares of Colgate-Palmolive from $94.00 to $95.00 and gave the company a “buy” rating in a research report on Monday, April 29th. Morgan Stanley increased their price objective on Colgate-Palmolive from $85.00 to $93.00 and gave the company an “overweight” rating in a research note on Monday, January 29th. JPMorgan Chase & Co. increased their price objective on Colgate-Palmolive from $88.00 to $90.00 and gave the company an “overweight” rating in a research note on Thursday, January 18th. TheStreet raised Colgate-Palmolive from a “c+” rating to a “b+” rating in a research note on Friday, January 26th. Finally, Wells Fargo & Company increased their price objective on Colgate-Palmolive from $90.00 to $92.00 and gave the company an “equal weight” rating in a research note on Monday, April 29th. Three research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $91.44.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.